Perkinelmer (PRIVATE.PERKINELMER)

Overall impact
B (70)

Commentary

Perkinelmer is a strong overall performer. With a 'B' rating of 69.6 for overall impact (81st percentile compared to all companies), Perkinelmer ranks 19th out of 41 industry peers, behind Agilent, LGC Group, Hoth Therapeutics and 15 others, and ahead of Eversana, SPT Labtech, Flourish Research and 19 others. On top material causes for Perkinelmer's industry (Life Sciences Tools & Services), Perkinelmer performs well in Sustainable Use of Water (87.2 score), Accountable Institutions (87.1), Disease Eradication (95.8) and 6 other causes where it received an 'A' score and performs poorly in Equal Pay and Opportunity (33.2 score) and Reduced Inequality (32.0).
Screens
Fur
Impact
Cause PRIVATE.PERKINELMER
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1931
Employees
16,700
Sector
Health Care
Industry
Life Sciences Tools & Services
Sub-industry
Life Sciences Tools & Services
SASB industry
Medical Equipment & Supplies
Headquarters
Ma, United States
Share classes
PRIVATE.PERKINELMER
Mission
To innovate for a healthier world.
Description
Provider of laboratory and field services catering to biopharma, food, environmental and safety and applied end markets. The company offers a portfolio of services including atomic spectroscopy, molecular spectroscopy, chromatography instruments, consumables and reagents.
Material causes
Ethos considers the following causes material for Perkinelmer, based on its industry sub-industry Life Sciences Tools & Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.